Federal contract award
75F40124C00130
THIS REQUIREMENT IS FOR THE GENERATION OF A BAA TO ADDRESS THE ONGOING GROWTH IN CONTINUOUS MANUFACTURING WITHIN CELL LINES. THIS REQUIREMENT IS BEING FUNDED THROUGH THE PRESIDENT'S TARGET INCREASE FOR FOCUS ON ADVANCE MANUFACTURING AND WILL FOC
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AJ11 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $1.8M |
| Current contract value | $1.8M |
| Potential contract value / ceiling | $6.0M |
| Start date | Sep 18, 2024 |
| Current end date | Jun 28, 2026 |
| Potential end date | Jun 28, 2026 |
| Latest award activity | Dec 22, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 4 of 4 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Dec 22, 2025 | P00003 | $0 | THIS REQUIREMENT IS FOR THE GENERATION OF A BAA TO ADDRESS THE ONGOING GROWTH IN CONTINUOUS MANUFACTURING WITHIN CELL LINES. THIS REQUIREMENT IS BEING FUNDED THROUGH THE PRESIDENT'S TARGET INCREASE FOR FOCUS ON ADVANCE MANUFACTURING AND WILL FOC |
| Aug 5, 2025 | P00002 | $0 | THIS REQUIREMENT IS FOR THE GENERATION OF A BAA TO ADDRESS THE ONGOING GROWTH IN CONTINUOUS MANUFACTURING WITHIN CELL LINES. THIS REQUIREMENT IS BEING FUNDED THROUGH THE PRESIDENT'S TARGET INCREASE FOR FOCUS ON ADVANCE MANUFACTURING AND WILL FOC |
| May 29, 2025 | P00001 | $0 | THIS REQUIREMENT IS FOR THE GENERATION OF A BAA TO ADDRESS THE ONGOING GROWTH IN CONTINUOUS MANUFACTURING WITHIN CELL LINES. THIS REQUIREMENT IS BEING FUNDED THROUGH THE PRESIDENT'S TARGET INCREASE FOR FOCUS ON ADVANCE MANUFACTURING AND WILL FOC |
| Sep 18, 2024 | 0 | $1.8M | THIS REQUIREMENT IS FOR THE GENERATION OF A BAA TO ADDRESS THE ONGOING GROWTH IN CONTINUOUS MANUFACTURING WITHIN CELL LINES. THIS REQUIREMENT IS BEING FUNDED THROUGH THE PRESIDENT'S TARGET INCREASE FOR FOCUS ON ADVANCE MANUFACTURING AND WILL FOC |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Ian Weiss | Contact | Ian.Weiss@fda.hhs.gov 3017965728 | Source | Jan 25, 2024 |
| Ian Weiss | Contact | Ian.Weiss@fda.hhs.gov 3017965728 | Source | Jan 16, 2024 |
| Ian Weiss | Contact | Ian.Weiss@fda.hhs.gov 3017965728 | Source | Dec 28, 2023 |
| Ian Weiss | Contact | Ian.Weiss@fda.hhs.gov 3017965728 | Source | Nov 2, 2023 |
| Ian Weiss | Contact | Ian.Weiss@fda.hhs.gov 3017965728 | Source | Oct 20, 2023 |
| Ian Weiss | Contact | Ian.Weiss@fda.hhs.gov 3017965728 | Source | Oct 18, 2023 |
| Ian Weiss | Contact | Ian.Weiss@fda.hhs.gov 3017965728 | Source | Oct 2, 2023 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.